Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-3,page-paged-3,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.3.0,vc_responsive

CLIENT NEWS

 

 

  • Abivax secures EUR 15m non-dilutive financing from Kreos Capital
    www.abivax.com
  • NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100™ (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19
    www.relieftherapeutics.com
  • Secarna Pharmaceuticals and Denali Therapeutics enter into research and option agreement to develop novel antisense therapies in the field of neurodegenerative diseases
    www.secarna.com
  • Rentschler Biopharma SE: Joining forces against SARS-CoV-2: Rentschler Biopharma contributes to manufacturing of COVID-19 mRNA vaccine
    www.rentschler-biopharma.com
  • Relief Therapeutics Appoints Industry Veteran, Jack Weinstein, as Chief Financial Officer and Treasurer
    www.relieftherapeutics.com
  • Paion AG reports progress with BYFAVO(TM) (remimazolam) by its licensee Acacia in the U.S.
    www.paion.com
  • NeuroRx and Relief Therapeutics Establish Supply and Distribution Agreements for RLF-100™ (aviptadil)
    www.relieftherapeutics.com
  • ECBF Management GmbH: Introduction of the new European Circular Bioeconomy Fund
    www.ecbc.vc
  • CENTOGENE’s Information Security Management System Awarded ISO/IEC 27001:2017 Accreditation
    www.centogene.com
  • Relief Announces Capital Increase from its Final Tranche of the Share Subscription Facility with GEM
    www.relieftherapeutics.com